Quantitative microbial risk assessment of pharmaceutical products

ME Eissa - PDA Journal of Pharmaceutical Science and …, 2016 - journal.pda.org
Monitoring of microbiological quality in the pharmaceutical industry is an important criterion
that is required to justify safe product release to the drug market. Good manufacturing …

[HTML][HTML] Distribution of bacterial contamination in non-sterile pharmaceutical materials and assessment of its risk to the health of the final consumers quantitatively

ME Eissa - Beni-Suef University Journal of Basic and Applied …, 2016 - Elsevier
Bacterial contamination control in pharmaceutical products is a critical aspect in the field of
drug manufacturing industry due to the encountered risk to the patients' health and possibly …

Microbiological contamination models for use in risk assessment during pharmaceutical production

W Whyte, T Eaton - European Journal of Parenteral and …, 2004 - eprints.gla.ac.uk
This paper describes the fundamental mechanisms of microbial contamination during
manufacture of pharmaceutical products. Models are derived that describe air and surface …

Assessing microbial risk to patients from aseptically manufactured pharmaceuticals

W Whyte - European Journal of Parenteral and Pharmaceutical …, 2004 - eprints.gla.ac.uk
The microbial risk to patients from aseptically manufactured pharmaceuticals is dependent
on the chance that a product contains sufficient microbes to initiate an infection. This …

Objectionable microorganisms in pharmaceutical production: Validation of a decision tree

S Burgalassi, S Ceccanti, S Vecchiani… - European Journal of …, 2021 - Elsevier
The release of quality, safe, and effective non-sterile drugs needs to exclude the presence of
objectionable microorganisms, which include microorganisms potentially involved in product …

Comparison of different calculation approaches for defining microbiological control levels based on historical data

O Gordon, M Goverde, J Pazdan, A Staerk… - PDA Journal of …, 2015 - journal.pda.org
In the present work we compared different calculation approaches for their ability to
accurately define microbiological control levels based on historical data. To that end, real …

A QRM discussion of microbial contamination of non-sterile drug products, using FDA and EMA warning letters recorded between 2008 and 2016

AMC Santos, MS Doria, L Meirinhos-Soares… - PDA Journal of …, 2018 - journal.pda.org
Microbial quality control of non-sterile drug products has been a concern to regulatory
agencies and the pharmaceutical industry since the 1960s. Despite being an old challenge …

Microbial contamination of nonsterile pharmaceuticals in public hospital settings

V Mugoyela, KD Mwambete - Therapeutics and clinical risk …, 2010 - Taylor & Francis
Purpose Contamination of pharmaceuticals with microorganisms irrespective whether they
are harmful or nonpathogenic can bring about changes in physicochemical characteristics of …

Setting threshold limits for the significance of objectionable microorganisms in oral pharmaceutical products

W Manu-Tawiah, BA Brescia… - PDA journal of …, 2001 - journal.pda.org
Due to the increasing number of immuno-compromised patients, increased attention is paid
to the quantitation and identification of microorganisms in oral pharmaceutical products; …

[BOOK][B] Pharmaceutical Microbiological Quality Assurance and Control: Practical Guide for Non-sterile Manufacturing

D Roesti, M Goverde - 2019 - books.google.com
Relying on practical examples from the authors' experience, this book provides a thorough
and modern approach to controlling and monitoring microbial contaminations during the …